PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 14984805-2 2004 Before the administration of formalin, NPY dose dependently increased blood pressure, an effect that could be prevented with the coadministration of the Y2 antagonist, BIIE0246. BIIE 0246 168-176 neuropeptide Y Rattus norvegicus 39-42 17976913-9 2008 NPY inhibition of SNI-induced Fos expression was localized to the sural (uninjured) innervation territory, and could be blocked by intrathecal BIBO3304 and BIIE0246. BIIE 0246 156-164 neuropeptide Y Rattus norvegicus 0-3 16081487-9 2005 In addition, compared to baseline, BIIE0246 infusion resulted in increased plasma neuropeptide Y concentration in females (P < 0.05), while there was no observable change in males. BIIE 0246 35-43 neuropeptide Y Rattus norvegicus 82-96 15927700-8 2005 The enhancement of the NPY induced increase in DOPA accumulation observed by BIBO3304 was attenuated when examined in the presence of the Y2 antagonist BIIE0246. BIIE 0246 152-160 neuropeptide Y Rattus norvegicus 23-26 18005069-6 2007 NPY was administered intracerebroventricularly, intrahippocampally via the microdialysis probe, or coadministered intrahippocampally with the D2 receptor antagonist remoxipride, the Y2 receptor antagonist BIIE0246 or the sigma 1 receptor antagonist BD1047. BIIE 0246 205-213 neuropeptide Y Rattus norvegicus 0-3 18005069-10 2007 Y2 receptor blockade (1 microm BIIE0246) reversed the anticonvulsant effect of NPY but did not prevent NPY-induced increases in hippocampal dopamine. BIIE 0246 31-39 neuropeptide Y Rattus norvegicus 79-82 17382974-8 2007 The Y2 antagonist BIIE0246 produced an attenuation of both the NPY and PYY3-36 induced enhancement while the Y1 antagonist BIBO3304 and theY5 antagonist CGP71683A failed to alter the NPY or PYY3-36 induced enhancement. BIIE 0246 18-26 neuropeptide Y Rattus norvegicus 63-66 17143304-11 2007 The Y2 receptor antagonist, BIIE0246, enhanced the inhibitory NPY effects. BIIE 0246 28-36 neuropeptide Y Rattus norvegicus 62-65 29852245-7 2018 This effect was diminished by both Y1 (BIBO3304) and Y2 (BIIE0246) receptor antagonists, indicating that both receptors participate in mediating the antinociceptive effect of NPY. BIIE 0246 57-65 neuropeptide Y Rattus norvegicus 175-178 12855401-11 2003 Pretreatment with the NPY-Y2 receptor antagonist BIIE-0246 (120 pmol) in the PVN had no significant effect. BIIE 0246 49-58 neuropeptide Y Rattus norvegicus 22-25 12377370-4 2002 Here, we examined the effects of a selective NPY-Y2 receptor antagonist, BIIE0246, on operant responding for ethanol in a sweetened solution, or the sweetened solution without ethanol, during 30 min sessions of free choice between the two. BIIE 0246 73-81 neuropeptide Y Rattus norvegicus 45-48 31736656-6 2019 Y2R agonist PYY (3-36) mimicked and Y2R antagonist BIIE0246 abolished the NPY effects in the mPFC. BIIE 0246 51-59 neuropeptide Y Rattus norvegicus 74-77 12623227-2 2003 The KCl-evoked release of glutamate from hippocampal synaptosomes was inhibited by 1 microM NPY and this effect was insensitive to either BIBP3226 (Y1 receptor antagonist) or L-152,804 (Y5 receptor antagonist), but was sensitive to BIIE0246 (Y2 receptor antagonist). BIIE 0246 232-240 neuropeptide Y Rattus norvegicus 92-95 12055128-9 2002 BIIE0246 (100 nM) completely suppressed the actions of NPY and [ahx(5-24)]NPY in this model. BIIE 0246 0-8 neuropeptide Y Rattus norvegicus 55-58 12055128-9 2002 BIIE0246 (100 nM) completely suppressed the actions of NPY and [ahx(5-24)]NPY in this model. BIIE 0246 0-8 neuropeptide Y Rattus norvegicus 74-77 12055128-11 2002 BIIE0246 potently suppresses NPY actions in rat hippocampus, suggesting a dominant role for Y(2)R there. BIIE 0246 0-8 neuropeptide Y Rattus norvegicus 29-32 11934810-8 2002 However, in the presence of BIIE 0246, a highly selective non-peptide NPY Y2-receptor antagonist, NPY was unable to increase 4-AP I(to) density. BIIE 0246 28-37 neuropeptide Y Rattus norvegicus 70-73 11934810-8 2002 However, in the presence of BIIE 0246, a highly selective non-peptide NPY Y2-receptor antagonist, NPY was unable to increase 4-AP I(to) density. BIIE 0246 28-37 neuropeptide Y Rattus norvegicus 98-101 10725255-9 2000 In the rat colon (a Y(2)/Y(4) bioassay), BIIE0246 (1 microM) completely blocked the contraction induced by PYY(3 - 36), but not that of [Leu(31), Pro(34)]NPY (a Y(1), Y(4) and Y(5) agonist) and hPP (a Y(4) and Y(5) agonist). BIIE 0246 41-49 neuropeptide Y Rattus norvegicus 154-157